BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Sep 01
Have your own idea? Try our Stock Screener
Markets has moved to Discover
You can now access Markets by navigating to Discover and selecting Markets.
Swedish (OMX) Biotech Industry Analysis
UpdatedSep 10, 2024
DataAggregated Company Financials
Companies65
- 7D1.1%
- 3M13.2%
- 1Y31.0%
- YTD14.1%
Over the last 7 days, the Biotech industry has risen 1.1%, driven by gains in Swedish Orphan Biovitrum and Vitrolife of 1.2% and 3.4%, respectively. In the last 12 months, the industry was up 31%. As for the next few years, earnings are expected to grow by 47% per annum.
Industry Valuation and Performance
Has the Swedish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 10 Sep 2024 | SEK 217.6b | SEK 31.5b | -SEK 5,557,002,759.46 | 51x | -39.2x | 6.9x |
| Thu, 08 Aug 2024 | SEK 193.1b | SEK 31.4b | -SEK 5,419,185,882.67 | 43x | -35.6x | 6.2x |
| Sat, 06 Jul 2024 | SEK 193.3b | SEK 30.6b | -SEK 5,537,801,084.49 | 38.9x | -34.9x | 6.3x |
| Mon, 03 Jun 2024 | SEK 198.9b | SEK 30.6b | -SEK 5,722,606,652.25 | 39.8x | -34.8x | 6.5x |
| Wed, 01 May 2024 | SEK 185.4b | SEK 30.8b | -SEK 5,544,266,153.62 | 50.5x | -33.4x | 6x |
| Fri, 29 Mar 2024 | SEK 185.1b | SEK 29.8b | -SEK 5,642,738,521.42 | 60.5x | -32.8x | 6.2x |
| Sun, 25 Feb 2024 | SEK 179.4b | SEK 29.8b | -SEK 5,768,696,000.91 | 51.4x | -31.1x | 6x |
| Tue, 23 Jan 2024 | SEK 187.8b | SEK 28.7b | -SEK 1,200,387,276.00 | 59x | -156.5x | 6.5x |
| Thu, 21 Dec 2023 | SEK 180.6b | SEK 28.7b | -SEK 1,169,327,462.00 | 60.3x | -154.4x | 6.3x |
| Sat, 18 Nov 2023 | SEK 166.9b | SEK 28.7b | -SEK 1,255,777,561.00 | 52.8x | -132.9x | 5.8x |
| Mon, 16 Oct 2023 | SEK 154.5b | SEK 27.4b | -SEK 1,963,051,432.00 | 48.8x | -78.7x | 5.6x |
| Wed, 13 Sep 2023 | SEK 150.5b | SEK 27.4b | -SEK 1,977,604,484.00 | 45.9x | -76.1x | 5.5x |
| Fri, 11 Aug 2023 | SEK 159.0b | SEK 27.5b | -SEK 1,575,693,675.00 | 53.4x | -100.9x | 5.8x |
| Sun, 09 Jul 2023 | SEK 160.8b | SEK 26.4b | -SEK 1,314,497,311.00 | 44.8x | -122.4x | 6.1x |
| Tue, 06 Jun 2023 | SEK 167.6b | SEK 26.4b | -SEK 1,191,274,285.00 | 45.9x | -140.7x | 6.4x |
| Thu, 04 May 2023 | SEK 175.0b | SEK 26.3b | -SEK 1,246,262,375.00 | 47.2x | -140.4x | 6.7x |
| Sat, 01 Apr 2023 | SEK 167.9b | SEK 25.4b | -SEK 2,016,129,138.00 | 38x | -83.3x | 6.6x |
| Mon, 27 Feb 2023 | SEK 170.0b | SEK 25.4b | -SEK 2,036,417,969.00 | 39.6x | -83.5x | 6.7x |
| Wed, 25 Jan 2023 | SEK 172.3b | SEK 23.8b | -SEK 1,838,166,502.00 | 32.4x | -93.8x | 7.2x |
| Fri, 23 Dec 2022 | SEK 156.7b | SEK 23.8b | -SEK 1,841,334,757.00 | 31.5x | -85.1x | 6.6x |
| Sun, 20 Nov 2022 | SEK 156.9b | SEK 23.8b | -SEK 1,761,618,179.00 | 32.1x | -89.1x | 6.6x |
| Tue, 18 Oct 2022 | SEK 153.0b | SEK 22.9b | -SEK 3,333,771,163.00 | 31.2x | -45.9x | 6.7x |
| Thu, 15 Sep 2022 | SEK 153.0b | SEK 22.9b | -SEK 3,248,058,622.00 | 32.9x | -47.1x | 6.7x |
| Sat, 13 Aug 2022 | SEK 172.6b | SEK 22.6b | -SEK 3,542,560,964.00 | 35x | -48.7x | 7.6x |
| Mon, 11 Jul 2022 | SEK 164.2b | SEK 21.4b | -SEK 3,520,210,178.00 | 40.3x | -46.7x | 7.7x |
| Wed, 08 Jun 2022 | SEK 157.8b | SEK 21.4b | -SEK 3,525,530,117.00 | 43.9x | -44.8x | 7.4x |
| Fri, 06 May 2022 | SEK 147.3b | SEK 21.3b | -SEK 3,505,394,673.00 | 42.1x | -42x | 6.9x |
| Sun, 03 Apr 2022 | SEK 175.9b | SEK 19.7b | -SEK 3,200,657,964.00 | 51.5x | -55x | 8.9x |
| Tue, 01 Mar 2022 | SEK 161.5b | SEK 19.7b | -SEK 2,959,932,143.00 | 50.5x | -54.6x | 8.2x |
| Thu, 27 Jan 2022 | SEK 164.6b | SEK 19.1b | -SEK 2,049,216,259.00 | 48.6x | -80.3x | 8.6x |
| Sat, 25 Dec 2021 | SEK 198.8b | SEK 19.1b | -SEK 2,004,036,910.00 | 52x | -99.2x | 10.4x |
| Mon, 22 Nov 2021 | SEK 204.4b | SEK 19.0b | -SEK 1,498,813,893.00 | 55.8x | -136.4x | 10.8x |
| Wed, 20 Oct 2021 | SEK 200.6b | SEK 18.1b | -SEK 1,349,751,367.00 | 48.4x | -148.6x | 11.1x |
| Fri, 17 Sep 2021 | SEK 217.7b | SEK 18.1b | -SEK 1,339,316,907.00 | 52.4x | -162.5x | 12x |
Price to Earnings Ratio
-162.5x
Current Industry PE
- Investors are relatively neutral on the Swedish Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 7.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 20% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | -2.60% | |
| Healthcare | 1.07% | |
| Biotech | 1.08% | |
| Biotech | 1.08% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SOBI Swedish Orphan Biovitrum | SEK 319.60 | 1.8% +SEK 1.9b | 44.6% | PE51x | |
| VITR Vitrolife | SEK 258.80 | 2.9% +SEK 974.8m | 96.8% | PS9.9x | |
| BIOA B BioArctic | SEK 174.80 | 5.8% +SEK 848.0m | -42.4% | PS51.6x | |
| BINV BioInvent International | SEK 45.25 | 12.8% +SEK 338.9m | 180.7% | PS56.5x | |
| SANION Saniona | SEK 4.95 | 14.1% +SEK 67.9m | -21.3% | PS22.1x |